Value of Investment in Health Care: Better Care, Better Lives (Executive Summary)
Over the past few decades, significant advances in the U.S. health care system have helped people live longer and better lives. Both mortality and disability rates have fallen consistently since the 1970's. This report endeavors to examine costs in the context of benefits received by focusing on overall improvements in health, as well as taking a specific look at four conditions (heart attack, type 2 diabetes, breast cancer, and stroke) that are among the most common causes of death and disability.
E.V.I.dently May 2013
Message From NPCThe Role of Pharmaceuticals in Health Insurance ExchangesOne of the most pressing issues in the implementation of the Affordable Care...
CER Tweets of the Week (Apr. 29 – May 3, 2013)
Conversations on Twitter about evidence and comparative effectiveness research highlighted the Agency for Healthcare Research and Quality’s call for...Evidence, Coverage and Incentives: Challenges in Personalized Medicine
Personalized medicine is greatly changing the way medicine is practiced, as well as how drugs and biologics are developed. Today patients are...E.V.I.dently April 2013
Message From NPCWhy Observational Studies MatterLast week, the Institute of Medicine (IOM), in conjunction with the Patient-Centered Outcomes...
Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Council’s Chairman of the Board
WASHINGTON, DC (November 2, 2012)–The National Pharmaceutical Council (NPC) today announced that John Gargiulo, President & CEO, Daiichi Sankyo,...New Survey Shows Employers Eyeing CER, PCORI for Health Information
Washington, DC, June 22, 2011--Employers are aware of comparative effectiveness research (CER) and its potential to answer critical questions about...Study Sheds New Light on the Impact of Medication Adherence, Multiple Chronic Diseases and Health Risks in the Workplace
(Chicago -- June 16, 2011) A new study suggests that while medication adherence is a critical element in reducing the impact of illness, employers...New Report Urges Employers, Researchers and Policy Makers to Rethink How They Measure Health Care Results
San Francisco, CA & Washington, DC (February 28, 2011) -- Understanding the full value of improved health, including improvements in workforce...
Living Up to Its Name? The Role of Patient-Centered Research
Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...The Risks of Standardized Health Care
Think about the last time you visited a medical office. Even at a specialist’s office, chances are that each person waiting for his or her name to be...Framework Helps ACOs Leverage Pharmaceuticals to Realize Quality, Cost Goals
Medications are more than an item on the balance sheet for health care providers. Pharmaceuticals offer a route to manage costs while achieving...Linking Chronic Conditions to Medication Adherence and Productivity
It's no secret that chronic disease is the major driver of health care costs in the United States, accounting for two-thirds of the rise in health...
Ensuring Inclusive and Diverse Research
Andre Williams, CEO of the Association of Black Cardiologists explains that research should be inclusive and diverse, taking racial, ethnic and...PCORI Outlines Efforts to Engage Patients
Dr. Rachael Fleurence, Scientist,Patient-Centered Outcomes Research Institute, outlines the many ways heragency is engaging patients and other...Do Patients Understand Comparative Effectiveness Research?
Marc Boutin, EVP...UPenn's Dr. Caplan on Communicating CER to Patients
Univ. of Pennsylvania Director of the Center for Bioethics Dr. Art Caplan outlines an ethical framework for communicating comparative effectiveness...CER Tweets of the Week (Apr. 29 – May 3, 2013)
Conversations on Twitter about evidence and comparative effectiveness research highlighted the Agency for Healthcare Research and Quality’s call for...Evidence, Coverage and Incentives: Challenges in Personalized Medicine
Personalized medicine is greatly changing the way medicine is practiced, as well as how drugs and biologics are developed. Today patients are...The Myth of Average: Why Individual Patient Differences Matter
How can comparative effectiveness research (CER) be conducted so that we understand which patients are likely to respond to what therapies? How can...The Role of Pharmaceuticals in the ACO Environment
Mark your calendars for October 16 from 2 pm-3pm ET and plan to participate in a special webinar about the role of pharmaceuticals in the accountable...Research
Pharmaceutical Benefits Under State Medical Assistance Programs, 2007
This report provides a compilation of data under state medical or state public medical assistance...
Pharmaceutical Benefits Under State Medical Assistance Programs, 2005
This report, part of the Pharmaceutical Benefits Und
Pharmaceutical Benefits Under State Medical Assistance Programs, 2004
This report, part of the Pharmaceutical Benefits Und
- 1 of 37
- >
Commentary & Testimony
Living Up to Its Name? The Role of Patient-Centered Research
The Risks of Standardized Health Care
Framework Helps ACOs Leverage Pharmaceuticals to Realize Quality, Cost Goals
Linking Chronic Conditions to Medication Adherence and Productivity
Comparative Effectiveness Research: What Will Employers Do With the Information?